SCHEMBL9274384

SCHEMBL9274384

CCC(=O)N1C(=O)OCC1(C)C(=O)N1CCN(c2ccccc2)CC1

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.46
ALDH1A1 P00352 4/20 0.46
HTR1A P08908 2/20 0.44
HTR7 P34969 2/20 0.44
LMNA P02545 2/20 0.44
NPSR1 Q6W5P4 1/20 0.44
MMP2 P08253 1/20 0.43
ADAMTS5 Q9UNA0 1/20 0.43
HSD17B10 Q99714 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.42
GRM5 P41594 1/20 0.42
MEN1 O00255 1/20 0.42
GAA P10253 1/20 0.42
KMT2A Q03164 1/20 0.42
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
AKR1C3 P42330 1/20 0.41
HPGD P15428 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12781874 0.74 MAPT (0.70) MAPTALDH1A1HTR1AHTR7LMNA
SCHEMBL9257560 0.72 TP53 (0.48) MAPTALDH1A1LMNA
SCHEMBL9274386 0.68 MAPT (0.47) MAPTALDH1A1HTR1AHTR7LMNA
SCHEMBL6958441 0.67 TP53 (0.36) MAPTALDH1A1LMNA
SCHEMBL14438077 0.67 MAPT (0.74) MAPTALDH1A1HTR1AHTR7LMNA
SCHEMBL12282092 0.66 MAPT (0.76) MAPTALDH1A1HTR1AHTR7LMNA
SCHEMBL13448477 0.66 KMT2A (0.57) MAPTALDH1A1HTR1AHTR7LMNA
SCHEMBL9274379 0.65 MAPT (0.51) MAPTALDH1A1HTR1AHTR7LMNA
SCHEMBL30528252 0.65 MAPT (0.86) MAPTALDH1A1HTR1AHTR7LMNA
SCHEMBL7840682 0.64 MAPT (0.72) MAPTALDH1A1HTR1AHTR7LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5378690-A Treatment of angiotensin induced hypertension SANKYO COMPANY, LIMITED (JP) 1995-01-03 US disclosed